|
(1) Synopsys' third quarter of fiscal year 2017 and 2016 ended on July 29, 2017 and July 30, 2016, respectively. For presentation purposes, we refer to the closest calendar month end. |
|
SYNOPSYS, INC. | ||||||
|
Unaudited Consolidated Balance Sheets (1) | ||||||
|
(in thousands, except par value amounts) | ||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
July 31, 2017 |
|
October 31, 2016 |
|
ASSETS: |
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
Cash and cash equivalents |
|
|
|
$ 1,154,986 |
|
$ 976,620 |
|
Short-term investments |
|
|
|
147,508 |
|
140,695 |
|
Total cash, cash equivalents and short-term investments |
|
|
|
1,302,494 |
|
1,117,315 |
|
Accounts receivable, net |
|
|
|
411,262 |
|
438,873 |
|
Income taxes receivable and prepaid taxes |
|
|
|
55,750 |
|
56,091 |
|
Prepaid and other current assets |
|
|
|
125,126 |
|
104,659 |
|
Total current assets |
|
|
|
1,894,632 |
|
1,716,938 |
|
Property and equipment, net |
|
|
|
262,025 |
|
257,035 |
|
Goodwill |
|
|
|
2,660,680 |
|
2,518,245 |
|
Intangible assets, net |
|
|
|
248,335 |
|
266,661 |
|
Long-term prepaid taxes |
|
|
|
15,706 |
|
13,991 |
|
Deferred income taxes |
|
|
|
382,495 |
|
281,926 |
|
Other long-term assets |
|
|
|
215,066 |
|
185,569 |
|
Total assets |
|
|
|
$ 5,678,939 |
|
$ 5,240,365 |
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS' EQUITY: |
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
Accounts payable and accrued liabilities |
|
|
|
$ 403,302 |
|
$ 401,451 |
|
Accrued income taxes |
|
|
|
16,270 |
|
22,693 |
|
Deferred revenue |
|
|
|
1,046,801 |
|
1,085,802 |
|
Short-term debt |
|
|
|
298,025 |
|
205,000 |
|
Total current liabilities |
|
|
|
1,764,398 |
|
1,714,946 |
|
Long-term accrued income taxes |
|
|
|
23,545 |
|
39,562 |
|
Long-term deferred revenue |
|
|
|
83,001 |
|
79,856 |
|
Long-term debt |
|
|
|
137,813 |
|
- |
|
Other long-term liabilities |
|
|
|
247,014 |
|
210,855 |
|
Total liabilities |
|
|
|
2,255,771 |
|
2,045,219 |
|
Stockholders' equity: |
|
|
|
|
|
|
|
Preferred stock, $0.01 par value: 2,000 shares authorized; none outstanding |
|
|
|
- |
|
- |
|
Common stock, $0.01 par value: 400,000 shares authorized; 150,238 and 151,454 shares outstanding, respectively |
|
|
|
|
|
|
|
|
|
|
1,503 |
|
1,515 | |
|
Capital in excess of par value |
|
|
|
1,631,200 |
|
1,644,675 |
|
Retained earnings |
|
|
|
2,277,499 |
|
1,947,585 |
|
Treasury stock, at cost: 7,024 and 5,811 shares, respectively |
|
|
|
(419,370) |
|
(294,052) |
|
Accumulated other comprehensive income (loss) |
|
|
|
(67,664) |
|
(104,577) |
|
Total stockholders' equity |
|
|
|
3,423,168 |
|
3,195,146 |
|
Total liabilities and stockholders' equity |
|
|
|
$ 5,678,939 |
|
$ 5,240,365 |
|
|
|
|
|
|
|
|
|
| ||||||
|
(1) Synopsys' third quarter of fiscal 2017 ended on July 29, 2017, and its fiscal year 2016 ended on October 29, 2016. For presentation purposes, we refer to the closest calendar month end. | ||||||
